Impax Asset Management Group plc Buys Shares of 698,910 Itron, Inc. $ITRI

Impax Asset Management Group plc purchased a new position in shares of Itron, Inc. (NASDAQ:ITRIFree Report) during the second quarter, HoldingsChannel reports. The fund purchased 698,910 shares of the scientific and technical instruments company’s stock, valued at approximately $91,998,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its stake in Itron by 119.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 77,060 shares of the scientific and technical instruments company’s stock worth $8,073,000 after buying an additional 41,984 shares during the period. Cerity Partners LLC increased its holdings in shares of Itron by 52.7% in the first quarter. Cerity Partners LLC now owns 4,928 shares of the scientific and technical instruments company’s stock worth $516,000 after acquiring an additional 1,701 shares in the last quarter. Xponance Inc. increased its holdings in shares of Itron by 5.7% in the first quarter. Xponance Inc. now owns 3,533 shares of the scientific and technical instruments company’s stock worth $370,000 after acquiring an additional 192 shares in the last quarter. Segall Bryant & Hamill LLC acquired a new stake in shares of Itron during the first quarter worth about $7,219,000. Finally, Bailard Inc. lifted its holdings in shares of Itron by 2.8% during the 1st quarter. Bailard Inc. now owns 29,801 shares of the scientific and technical instruments company’s stock valued at $3,122,000 after purchasing an additional 800 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Activity

In related news, SVP Donald L. Reeves III sold 547 shares of the firm’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $68,544.57. Following the completion of the transaction, the senior vice president directly owned 19,604 shares of the company’s stock, valued at approximately $2,456,577.24. This trade represents a 2.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joan S. Hooper sold 970 shares of the company’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the sale, the chief financial officer directly owned 88,394 shares in the company, valued at approximately $11,076,652.14. The trade was a 1.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 3,037 shares of company stock valued at $380,566. Corporate insiders own 1.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ITRI shares. Robert W. Baird reiterated a “neutral” rating and issued a $118.00 price objective (down from $137.00) on shares of Itron in a research report on Friday, October 31st. JPMorgan Chase & Co. lifted their price target on shares of Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday, October 16th. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Weiss Ratings restated a “buy (b)” rating on shares of Itron in a report on Wednesday, October 8th. Finally, Baird R W lowered shares of Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, Itron presently has a consensus rating of “Moderate Buy” and an average target price of $139.00.

Read Our Latest Stock Report on ITRI

Itron Stock Performance

Shares of ITRI stock opened at $104.88 on Thursday. The firm has a market cap of $4.80 billion, a PE ratio of 17.93, a P/E/G ratio of 0.76 and a beta of 1.52. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $142.00. The company’s fifty day simple moving average is $121.82 and its 200-day simple moving average is $123.11. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.48 by $0.06. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm had revenue of $581.63 million for the quarter, compared to analysts’ expectations of $578.49 million. During the same period in the previous year, the firm posted $1.84 EPS. The company’s revenue for the quarter was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. Equities research analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Itron Profile

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Stories

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRIFree Report).

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.